Henlius Raises Stakes In Denosumab Race With Phase I Completion

HLX14 Denosumab Biosimilar Scores PK Trial Win; Submissions Expected Later This Year

 
• By Adam Zamecnik
  
Denosumab syringes
Henlius’ Denosumab Biosimilar HLX14 Passes Phase I Test • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products